Furthermore, therapies aimed at reducing CCL7 levels or blocking its receptor could potentially mitigate the inflammatory and insulin-resistant aspects of PCOS, paving the way for novel treatment strategies. The gene discussed is CCL7; the disease is polycystic ovary syndrome.